Medici Medical Ltd, Israel

Haemophilus Influenzae type b 10 mcg / 0.5 ml.
VIALS: (pwdr.) 1 + syringe: 0.5 ml. I.M or
S.C. route. See lit.
Prevent. in inf. against invas. dis.
caused by H. influenza type B such as
meningit., septicem., cellulit., arthrit.,
epiglotit.
C/I: Hypersens., espec. tetanus protein.

Tetanus Toxoid 5 Lf, Diphtheria Toxoid 2 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Pertactin 3 mcg, Fimbriae Types 2+3 5 mcg.
Cont. in 0.5 ml :
Diphtheria Toxoid 2 Lf ;Tetanus Toxoid 5 Lf ;
Pertussis Toxoid 2.5 microg; Filamentous Haemagglutinin 5 microg;
Pertactin 3 microg; Fimbriae Types 2 and 3 5 microg;
Aluminium (aluminium phosphate by calc.) 0.33 mg (1.5mg)
VIAL: 1/5/10 x 0.5 ml. susp for I.M.  inj. into deltoid musc.
 Immun. schedule as per health auth. recommen. Re-dosing at 5-10 years  interval. See lit.
 Active booster immun. for the prevent. of tetanus, diphtheria and pertussis in childr, adolesc. and adlts aged 4 to 64 years. Not for use as dis. tmt.
C/I:Hypersens. Encephalopathy of unknown origin within 7 days of prev. immuniz. with a pertussis-cont. vacc. To be postponed in persons suffering from an ac. sev. febrile illness. Minor infect. is not a contraind.

Diphtheria Toxoid Not less than 2 IU, Tetanus Immuneglobulin 5 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Fimbriae Types 2+3 5 mcg, Pertactin 3 mcg, Poliomyelitis Virus Type 1 40 D-antigen units, Poliomyelitis Virus Type 2 8 D-antigen units, Poliomyelitis Virus Type 3 32 D-antigen units.
PRE-FILLED SYRINGES (susp. for inject.):
1, 10, 20. Starting from age 3, a single
I.M. 0.5 ml dose, in deltoid muscle,
applies to all age groups.
Active booster immunisat. for prevent.
diphth., tetanus, pertussis and polio,
from 3 yrs and over.
C/I: Hypersens., anaphylact./allerg.
reacts. to similar vaccine,
encephalopath. of unknown origin
within 7 days of prev. immunisat. dose
of any vaccine cont. pertussis antigens
(whole cell or acellular). Progress.
neurolog. disords., uncontroll. epilepsy,
progress. encephalopath. until tmt.
regimen established. Febrile or acute
illness. See lit.

Hepatitis A Virus Antigen (Inactivated) 80 U / 0.5 ml.
SUSP. FOR INJECT. (single dose prefilled
syringe): 1. Prim. vaccinat: 0.5 ml.
Booster within 6-8 mths. foll. initial dose.
I.M. in deltoid. See lit.
SUSP. FOR INJECT. (multidose vial): 10 x
0.5 ml. As above
Active immunizat. against hepatit. A
virus in child 12 mths-15 yrs (inclus.).
C/I: Hypersens. to active ingred.,
neomycin, polysorbate, foll. prev. inject.
Feber, acute/chron. evolv. dis. See lit.

Human Coagulation Factor VIII 25, 50, 100 IU/ml.
VIAL: 1 x 250 IU, 500 IU, 1,000 IU (+ 10 ml
solv. in prefill. syringe). Adjust dose and
durat. accord. to pts needs.
Prevent. and control bleed. in mod. or
severe Factor VIII defic., due to classic.
hemophil. A. Not effect. in control. bleed.
Von Willebrand’s dis.
C/I: Allergic. reacts. to constits.

Human Normal Immunoglobulin 0.5 g / 10 ml.
VIALS: 1 x 0.5 g, 2.5 g, 5 g, 10 g. See lit.
Replacement ther. in: Prim. immunodefic.
synds. such as: congen.
agammaglobulinem./
hypogammaglobulinem; common
variable immunodefic.; severe combined
immunodefic.; Wiscott Aldrich syndr.
Myeloma/chron. lympocyt. leukem. with
severe second. hypogammaglobuline.
and recurr. infects. Child with congenital
AIDS and recurr. infects.
Immunomodulat: ITP in child or adults at
high risk of bleed./prior to surgery to
correct the platelet count. Guillain Barre
syndr., Kawasaki dis., allogeneic bone
marrow transplant.
C/I: History anaphylact. or severe
system. response to I.M./I.V.
immunoglob. preps.